Quoin Pharmaceuticals (QNRX) Balance Sheet: Assets & Liabilities

Quoin Pharmaceuticals (QNRX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Quoin Pharmaceuticals reported total assets of $20.39M and total liabilities of $7.27M. Shareholders' equity was $13.12M, up 42.5% from $9.20M a year earlier. Total debt stood at $2.32M against $18.75M in cash and short-term investments, a net cash position of $16.42M. That puts debt-to-equity at 0.18, compared with 0.32 a year earlier.

Quoin Pharmaceuticals Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Quoin Pharmaceuticals, Ltd. (QNRX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Mar 2020	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	3.82	3.62	2.40	2.86	7.48	0.32	5.24	4.77	3.96
Short-Term Investments	14.93	10.43	8.29	9.99	0.00	0.00	0.00	0.00	4.03
Cash & Short-Term Investments	18.75	14.06	10.69	12.85	7.48	0.32	5.24	4.77	7.99
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.08	0.06	0.07
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.26	0.87	0.59	0.52	0.72	0.14	0.06	0.16	0.17
Total Current Assets	20.01	14.93	11.29	13.37	8.20	0.47	5.38	4.98	8.22
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00	0.00	1.94	0.67	0.41	0.39
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.12	0.13	0.14
Intangible Assets	0.38	0.48	0.58	0.70	0.81	0.91	1.02	0.00	0.00
Other Non-Current Assets	-382.95	0.30	0.30	0.38	0.35	-1.94	0.00	0.00	0.00
Total Non-Current Assets	0.38	0.78	0.88	1.09	1.16	0.91	0.79	0.54	0.52
Total Assets	20.39	15.71	12.17	14.46	9.36	1.38	6.17	5.52	8.75
Current Liabilities
Accounts Payable	1.26	0.91	0.53	0.61	0.92	0.00	0.05	0.24	0.49
Short-Term Debt	0.60	0.60	0.60	0.00	0.00	1.21	0.11	0.00	0.00
Current Portion of Long-Term Debt	0.60	0.60	0.60	0.60	0.60	-	-	-	-
Accrued Liabilities	3.24	2.60	2.45	2.16	2.68	4.99	-	-	-
Other Current Liabilities	4.28	3.20	2.96	2.76	3.45	6.62	0.89	1.07	0.69
Total Current Liabilities	5.55	4.18	3.58	3.53	4.58	7.99	1.05	1.31	1.18
Non-Current Liabilities
Long-Term Debt	1.72	2.32	2.92	0.00	0.00	0.00	0.20	0.00	0.00
Other Non-Current Liabilities	1.72	2.32	2.92	3.52	4.12	0.00	0.63	0.49	2.14
Total Non-Current Liabilities	1.72	2.32	2.92	3.52	4.12	0.00	0.82	0.49	2.14
Total Liabilities	7.27	6.50	6.51	7.05	8.70	7.99	1.88	1.80	3.32
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-70.97	-55.17	-46.20	-37.52	-28.07	-6.61	-29.20	-22.49	-18.42
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	4.79	3.30	2.70
Treasury Stock	-	-	-	2.93	2.93	-	-	-	-
Additional Paid-in Capital	84.09	64.37	51.87	47.86	28.73	0.00	28.71	22.92	21.15
Shares Outstanding	52.44	8.95	0.99	0.40	0.06	-	-	-	-
Total Stockholders' Equity	13.12	9.20	5.66	7.41	0.66	-6.61	4.30	3.73	5.43
Total Liabilities & Equity	20.39	15.71	12.17	14.46	9.36	1.38	6.17	5.52	8.75

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Quoin Pharmaceuticals Balance Sheet

How much debt does Quoin Pharmaceuticals have?

Quoin Pharmaceuticals had total debt of $2.32M as of Dec 31, 2025, against $18.75M in cash and short-term investments. Its debt-to-equity ratio was 0.18. Total debt was $2.92M a year earlier.

What are Quoin Pharmaceuticals's total assets?

Quoin Pharmaceuticals reported total assets of $20.39M as of Dec 31, 2025, up 29.8% from $15.71M a year earlier. Total liabilities were $7.27M.

What is Quoin Pharmaceuticals's shareholders' equity?

Quoin Pharmaceuticals's shareholders' equity was $13.12M as of Dec 31, 2025, or about $0.25 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition